アルファシヌクレインマウスにおけるドーパミナージック損失とインクルージョンボディ形成:神経変性障害への影響
E Masliah1, E Rockenstein, I Veinbergs
1Department of Neurosciences, Department of Pathology, University of California San Diego, La Jolla, CA 92093-0624, USA. emasliah@ucsd.edu
Science (New York, N.Y.)
|February 26, 2000
まとめ
この研究は,ニューロンにアルファ-シヌクレインタンパク質が蓄積され,脳細胞の損傷と運動の欠損を引き起こすことを示しています. これらの発見は,アルファ-シヌクレインがパーキンソン病の病原性において重要な役割を果たすことを示唆しています.
科学分野:
- 神経科学は神経科学である.
- 分子生物学は分子生物学である.
- 神経変性疾患 神経変性疾患
背景:
- アルファシヌクレインは,神経変性疾患に関与するシナプスタンパク質です.
- 病気の病原性におけるその正確な役割は,まだ完全に理解されていません.
研究 の 目的:
- 野生型のアルファ-シナヌクレインが脳に蓄積する機能的役割を調査する.
- アルファ-シヌクレインの集積が神経機能障害や運動欠陥に寄与するかどうかを判断する.
主な方法:
- 野生型ヒトアルファ-シヌクレインを発現するトランスジェニックマウスの生成.
- ニューロンのインクルージョンにおけるアルファシヌクレインとウビキチン免疫活性性の分析.
- ニューロンの堆積 (核内および細胞膜内) の超構造的検査.
- ドーパミナージック端末の完全性と運動機能の評価.
主要な成果:
- 人間のアルファ-シヌクレインのニューロン発現は,新皮質,海馬,黒い物質のアルファ-シヌクレインとユビキチン含有物の漸進的な蓄積につながった.
- 超構造的分析により,核内および細胞プラズマのインクルージョンが確認されました.
- 観察された変化は,基礎状腺におけるドーパミナージック端末の喪失と,重要な運動障害と相関する.
結論:
- 野生型アルファシヌクレインの蓄積は,神経病変と機能的欠陥を引き起こす可能性があります.
- これらの発見は,パーキンソン病および関連するシヌクレイン症候群の発達におけるアルファ-シヌクレイン集積の因果的な役割を強く示唆しています.
関連する概念動画
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...